Neutralizing antibodies to SARS-CoV-2 Omicron variant after 3rd mRNA vaccination in health care workers and elderly subjects and response to a single dose in previously infected adults
View ORCID ProfileAnu Haveri, Anna Solastie, Nina Ekström, Pamela Österlund, Hanna Nohynek, Tuomo Nieminen, Arto A. Palmu, Merit Melin
doi: https://doi.org/10.1101/2021.12.22.21268273
Anu Haveri
1Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland
Anna Solastie
1Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland
Nina Ekström
1Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland
Pamela Österlund
1Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland
Hanna Nohynek
1Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland
Tuomo Nieminen
2Department of Information Services, Finnish Institute for Health and Welfare, Helsinki, Finland
Arto A. Palmu
3Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Tampere, Finland
Merit Melin
1Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Data subject to third party restrictions. The data that support the findings of this study are available from Finnish Social and Health Data Permit Authority Findata. Restrictions apply to the availability of these data, which were used under license for this study under informed consent form. Anonymized data are available after permission by Findata.
Posted December 24, 2021.
Neutralizing antibodies to SARS-CoV-2 Omicron variant after 3rd mRNA vaccination in health care workers and elderly subjects and response to a single dose in previously infected adults
Anu Haveri, Anna Solastie, Nina Ekström, Pamela Österlund, Hanna Nohynek, Tuomo Nieminen, Arto A. Palmu, Merit Melin
medRxiv 2021.12.22.21268273; doi: https://doi.org/10.1101/2021.12.22.21268273
Neutralizing antibodies to SARS-CoV-2 Omicron variant after 3rd mRNA vaccination in health care workers and elderly subjects and response to a single dose in previously infected adults
Anu Haveri, Anna Solastie, Nina Ekström, Pamela Österlund, Hanna Nohynek, Tuomo Nieminen, Arto A. Palmu, Merit Melin
medRxiv 2021.12.22.21268273; doi: https://doi.org/10.1101/2021.12.22.21268273
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (670)
- Anesthesia (181)
- Cardiovascular Medicine (2652)
- Dermatology (224)
- Emergency Medicine (400)
- Epidemiology (12242)
- Forensic Medicine (10)
- Gastroenterology (762)
- Genetic and Genomic Medicine (4113)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2664)
- Health Policy (1005)
- Hematology (364)
- HIV/AIDS (852)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (439)
- Neurology (3897)
- Nursing (210)
- Nutrition (578)
- Oncology (2037)
- Ophthalmology (586)
- Orthopedics (241)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (452)
- Public and Global Health (6537)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (410)
- Sports Medicine (343)
- Surgery (451)
- Toxicology (53)
- Transplantation (185)
- Urology (166)